Transfection of an active cytochrome P450 arachidonic acid epoxygenase indicates that 14,15-epoxyeicosatrienoic acid functions as an intracellular second messenger in response to epidermal growth factor
Jk. Chen et al., Transfection of an active cytochrome P450 arachidonic acid epoxygenase indicates that 14,15-epoxyeicosatrienoic acid functions as an intracellular second messenger in response to epidermal growth factor, J BIOL CHEM, 274(8), 1999, pp. 4764-4769
A common feature of most isolated cell systems is low or undetectable level
s of bioactive cytochrome P450. We therefore developed stable transfectants
of the renal epithelial cell line, LLCPKc14, that expressed an active regi
o- and enantioselective arachidonic acid (AA) epoxygenase, Site-specific mu
tagenesis was used to convert bacterial P450 BM-3 into an active regio- and
stereoselective 14S,15R-epoxygenase (F87V BM-3). In clones expressing F87V
BM-3 (F87V BM-3 cells), exogenous AA induced significant 14S,15R-epoxyeico
satrienoic acid (EET) production (241.82 ng/10(8) cells, >97% of total EETs
), whereas no detectable EETs were seen in cells transfected with vector al
one. In F87V BM-3 cells, AA stimulated [H-3]thymidine incorporation and inc
reased cell proliferation, which was blocked by the tyrosine kinase inhibit
or, genistein, by the phosphatidylinositol 3 (PI-3) kinase inhibitors, wort
mannin and LY294002, and by the mitogen-activated protein kinase kinase inh
ibitor, PD98059. AA also induced tyrosine phosphorylation of extracellular
signal-regulated kinase (ERK) and PI-3 kinase that was inhibited by the cyt
ochrome P450 BM-3 inhibitor, 17-ODYA. Epidermal growth factor (EGF) increas
ed EET production in F87V BM-3 cells, which was completely abolished by pre
treatment with either 17-ODYA or the phospholipase A(2) (PLA(2)) inhibitor,
quinacrine, Compared with vector-transfected cells, F87 BM-3 transfected c
ells demonstrated marked increases in both the extent and sensitivity of DN
A synthesis in response to EGF. These changes occurred in the absence of si
gnificant differences in EGF receptor expression. As seen with exogenous AA
, EGF increased ERK tyrosine phosphorylation to a significantly greater ext
ent in F87V BM-3 cells than in vector-transfected cells. Furthermore, in th
ese control cells, neither 17-ODYA nor quinacrine inhibited EGF-induced ERK
tyrosine phosphorylation. On the other hand, in F87V BM-3 cells, both inhi
bitors reduced ERK tyrosine phosphorylation to levels indistinguishable fro
m that seen in cells transfected with vector alone.
These studies provide the first unequivocal evidence for a role for the AA
epoxygenase pathway and endogenous EET synthesis in EGF-mediated signaling
and mitogenesis and provide compelling evidence for the PL2-AA-EET pathway
as an important intracellular-signaling pathway in cells expressing high le
vels of cytochrome P450 epoxygenase.